These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 15769641)
21. Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression. Shukla S; MacLennan GT; Fu P; Patel J; Marengo SR; Resnick MI; Gupta S Neoplasia; 2004; 6(4):390-400. PubMed ID: 15256061 [TBL] [Abstract][Full Text] [Related]
22. The crystal structure of the IkappaBalpha/NF-kappaB complex reveals mechanisms of NF-kappaB inactivation. Huxford T; Huang DB; Malek S; Ghosh G Cell; 1998 Dec; 95(6):759-70. PubMed ID: 9865694 [TBL] [Abstract][Full Text] [Related]
23. Differential expression of the transcription factor NF-kappaB during human mononuclear phagocyte differentiation to macrophages and dendritic cells. Ammon C; Mondal K; Andreesen R; Krause SW Biochem Biophys Res Commun; 2000 Feb; 268(1):99-105. PubMed ID: 10652220 [TBL] [Abstract][Full Text] [Related]
24. Increased expression of p50-NF-kappaB and constitutive activation of NF-kappaB transcription factors during mouse skin carcinogenesis. Budunova IV; Perez P; Vaden VR; Spiegelman VS; Slaga TJ; Jorcano JL Oncogene; 1999 Dec; 18(52):7423-31. PubMed ID: 10602501 [TBL] [Abstract][Full Text] [Related]
25. The nuclear I kappaB protein I kappaB zeta specifically binds NF-kappaB p50 homodimers and forms a ternary complex on kappaB DNA. Trinh DV; Zhu N; Farhang G; Kim BJ; Huxford T J Mol Biol; 2008 May; 379(1):122-35. PubMed ID: 18436238 [TBL] [Abstract][Full Text] [Related]
26. Site-Selective Tyrosine Phosphorylation in the Activation of the p50 Subunit of NF-κB for DNA Binding and Transcription. Chen S; Ji X; Dedkova LM; Potuganti GR; Hecht SM ACS Chem Biol; 2023 Jan; 18(1):59-69. PubMed ID: 36534507 [TBL] [Abstract][Full Text] [Related]
27. A molecular modeling study of inhibitors of nuclear factor kappa-B (p50)--DNA binding. Pande V; Sharma RK; Inoue J; Otsuka M; Ramos MJ J Comput Aided Mol Des; 2003 Dec; 17(12):825-36. PubMed ID: 15124931 [TBL] [Abstract][Full Text] [Related]
28. Coexpression of Notch1 and NF-kappaB signaling pathway components in human cervical cancer progression. Ramdass B; Maliekal TT; Lakshmi S; Rehman M; Rema P; Nair P; Mukherjee G; Reddy BK; Krishna S; Radhakrishna Pillai M Gynecol Oncol; 2007 Feb; 104(2):352-61. PubMed ID: 17098279 [TBL] [Abstract][Full Text] [Related]
29. Constitutive activation of nuclear factor κB contributes to cystic fibrosis transmembrane conductance regulator expression and promotes human cervical cancer progression and poor prognosis. Wu Z; Peng X; Li J; Zhang Y; Hu L Int J Gynecol Cancer; 2013 Jun; 23(5):906-15. PubMed ID: 23640294 [TBL] [Abstract][Full Text] [Related]
30. I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding. Ganchi PA; Sun SC; Greene WC; Ballard DW Mol Biol Cell; 1992 Dec; 3(12):1339-52. PubMed ID: 1493333 [TBL] [Abstract][Full Text] [Related]
31. Effects of glucocorticoids on tumor necrosis factor alpha-dependent activation of nuclear factor kappaB and expression of the intercellular adhesion molecule 1 gene in osteoblast-like ROS17/2.8 cells. Kurokouchi K; Kambe F; Kikumori T; Sakai T; Sarkar D; Ishiguro N; Iwata H; Seo H J Bone Miner Res; 2000 Sep; 15(9):1707-15. PubMed ID: 10976991 [TBL] [Abstract][Full Text] [Related]
32. Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo. Duffey DC; Chen Z; Dong G; Ondrey FG; Wolf JS; Brown K; Siebenlist U; Van Waes C Cancer Res; 1999 Jul; 59(14):3468-74. PubMed ID: 10416612 [TBL] [Abstract][Full Text] [Related]
33. Mercuric ion attenuates nuclear factor-kappaB activation and DNA binding in normal rat kidney epithelial cells: implications for mercury-induced nephrotoxicity. Dieguez-Acuña FJ; Ellis ME; Kushleika J; Woods JS Toxicol Appl Pharmacol; 2001 Jun; 173(3):176-87. PubMed ID: 11437639 [TBL] [Abstract][Full Text] [Related]
34. High expression levels of nuclear factor kappa B and gelatinases in the tumorigenesis of oral squamous cell carcinoma. Bindhu OS; Ramadas K; Sebastian P; Pillai MR Head Neck; 2006 Oct; 28(10):916-25. PubMed ID: 16823875 [TBL] [Abstract][Full Text] [Related]
35. Structure of NF-kappaB p50/p65 heterodimer bound to the PRDII DNA element from the interferon-beta promoter. Escalante CR; Shen L; Thanos D; Aggarwal AK Structure; 2002 Mar; 10(3):383-91. PubMed ID: 12005436 [TBL] [Abstract][Full Text] [Related]
36. Activation of transcriptionally active nuclear factor-kappaB by tumor necrosis factor-alpha and its inhibition by antioxidants in rat thyroid FRTL-5 cells. Kikumori T; Kambe F; Nagaya T; Imai T; Funahashi H; Seo H Endocrinology; 1998 Apr; 139(4):1715-22. PubMed ID: 9528954 [TBL] [Abstract][Full Text] [Related]
37. CD40L induces matrix-metalloproteinase-9 but not tissue inhibitor of metalloproteinases-1 in cervical carcinoma cells: imbalance between NF-kappaB and STAT3 activation. Smola-Hess S; Schnitzler R; Hadaschik D; Smola H; Mauch C; Krieg T; Pfister H Exp Cell Res; 2001 Jul; 267(2):205-15. PubMed ID: 11426939 [TBL] [Abstract][Full Text] [Related]
38. Nuclear factor NF-kappa B in myocardium: developmental expression of subunits and activation by interleukin-1 beta in cardiac myocytes in vitro. Norman DA; Yacoub MH; Barton PJ Cardiovasc Res; 1998 Aug; 39(2):434-41. PubMed ID: 9798528 [TBL] [Abstract][Full Text] [Related]
39. Regulation of intercellular adhesion molecule-1 gene by tumor necrosis factor-alpha is mediated by the nuclear factor-kappaB heterodimers p65/p65 and p65/c-Rel in the absence of p50. Aoudjit F; Brochu N; Bélanger B; Stratowa C; Hiscott J; Audette M Cell Growth Differ; 1997 Mar; 8(3):335-42. PubMed ID: 9056676 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of nuclear factor-kappaB activation confers sensitivity to tumor necrosis factor-alpha by impairment of cell cycle progression in human glioma cells. Otsuka G; Nagaya T; Saito K; Mizuno M; Yoshida J; Seo H Cancer Res; 1999 Sep; 59(17):4446-52. PubMed ID: 10485496 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]